|
Year | iFLYTEK innovation event | iFLYTEK business event |
|
1999 | Speech-synthesis evaluation scored more than 3.0 | IFLYTEK was founded |
2001 | iFLYTEK undertook the national voice high-technology industrialization demonstration project and set up a postdoctoral research workstation | iFLYTEK completed its second round of financing and cooperated with Nuance, which is the world’s leading voice company, to provide an automatic response scheme |
2004 | In the international evaluation of Chinese speech synthesis, iFLYTEK ranked first for all indicators | iFLYTEK achieved profit and loss balance for the first time, and its sales exceeded 100 million yuan for the first time |
2005 | The iFLYTEK Research Institute of Science and Technology was officially established and won the “major technological invention award of information industry” | iFLYTEK’s voice product revenue reached 150 million yuan, driving the industry by about 1 billion yuan |
2008 | iFLYTEK won first prize in the International Speech Synthesis Competition and first prize in the Global Speaker Competition, becoming a “China’s national innovative pilot enterprise” | iFLYTEK was listed on the Shenzhen Stock Exchange, and the construction of the voice industry base was started, with a revenue of 257 million in 2008 |
2010 | iFLYTEK won first prize in the International Competition of English Speech Synthesis and became one of the top ten independent innovation brands of intellectual property rights in China’s software industry | iFLYTEK released “iFLYTEK Voice Cloud” and “Voice Input Method” and established a national intelligent voice high-tech industrial base |
2012 | iFLYTEK’s first-generation speech recognition system, which uses deep trust network technology, improved its performance in telephone transcribing and speech dictation | iFLYTEK’s Voice Cloud end users exceeded 150 million, with it becoming the largest voice-listed company in the Asia Pacific region and the software company with the highest market value in the Shanghai and Shenzhen stock markets of China (“New generation of ‘voice cloud’ released by iFLYTEK,” NetEase News, March 23, 2012, http://news.163.com/12/0323/12/7T9G6BI700014AEE.html) |
Breakthroughs were made in a number of core technologies to effectively solve technical problems such as antinoise, accent adaptation, and personalized vocabulary |
2013 | iFLYTEK’s multivoice synthesis products covered 25 major languages in the world, filled gaps in China, and overcame the key technologies of voice recognition, such as digital voice code and deep learning language recognition | iFLYTEK established a comprehensive strategic cooperative relationship with the three major telecom operators. iFLYTEK had over 350 million voice cloud downloads and activations and over 100 million voice input users |
2014 | iFLYTEK launched the “iFLYTEK Super Brain Program” | iFLYTEK released 3.0 smart voice products and the iFLYTEK Voice Cloud, with an annual revenue of 1.77 billion, more than 600 million end users of the iFLYTEK Voice Cloud, and more than 55,000 development cooperation projects |
2015 | iFLYTEK released the human-computer voice interface, defining the new standard of human and voice interaction technology in the era of the Internet of Things | iFLYTEK and JingDong performed strategic cooperation and released the DingDong smart speaker. The total number of users of iFLYTEK’s open platform was 700 million, with 300 million users of iFLYTEK’s input method and 18 dialects supported (https://xueqiu.com/2143043140/135269696) |
2017 | iFLYTEK launched “AI education,” entered the medical field, and released its “intelligent medical assistant” | iFLYTEK’s open platform had more than 3 billion online daily services, 250,000 partners, and 910 million users (https://www.yicai.com/news/5424180.html). iFLYTEK accounted for more than 60% of the market share in the field of Chinese speech technology and more than 70% of the market share in the field of speech synthesis products |
2019 | iFLYTEK deeply explored the new combinations of voice AI in the fields of medical treatment, media, education, politics, and law | |
|